Exploring the clinical utility of Oncotype DX in ER+/HER2-, N0 and N1 breast cancer patients: Insights from a Romanian cohort

被引：0

作者：

Blidaru, A. ^{[1
]}

Zob, D. ^{[2
]}

Schenker, M. ^{[3
]}

Onisim, A. ^{[4
]}

Bodale, C. ^{[5
]}

Curca, R. ^{[6
]}

Negru, S. ^{[7
]}

Oprean, C. ^{[7
]}

Curescu, P. ^{[8
]}

Gafton, B. ^{[9
]}

Volovat, S. ^{[9
]}

Mihaila, R. ^{[2
]}

Filip, G. ^{[10
]}

Median, D. ^{[11
]}

Dediu, M. ^{[12
]}

Chetroiu, D. ^{[13
]}

Pantelimon, I. ^{[14
]}

Costovici, C. ^{[15
]}

Viisoreanu, C. G. ^{[16
]}

Titirez, V. ^{[17
]}

Mateescu, D. ^{[17
]}

Gal, C. ^{[17
]}

Vremes, G. ^{[18
]}

Stanculeanu, D. -L. ^{[1
]}

Tsoulos, N. ^{[19
]}

Kapetsis, G. ^{[19
]}

Giannoulakis, S. ^{[19
]}

Sires, A.

Chirnogea, A. ^{[20
]}

Maxim, A. -I. ^{[20
]}

Iorga, P. ^{[21
]}

Jinga, D. -C. ^{[22
]}

Nitipir, C. ^{[23
]}

机构：

[1] Alexandru Trestioreanu Inst, Bucharest, Romania

[2] Bucharest Oncol Inst, Bucharest, Romania

[3] St Nectarie Oncol Ctr, Craiova, Romania

[4] Medisprof Cluj Napoca, Cluj Napoca, Romania

[5] Amethyst Cluj Napoca, Cluj Napoca, Romania

[6] Elysee Alba Iulia, Alba Iulia, Romania

[7] OncoHelp Timisoara, Timisoara, Romania

[8] Timisoara Municipal Hosp, Timisoara, Romania

[9] Reg Inst Oncol Iasi, Iasi, Romania

[10] Ponderas Acad Hosp Regina Maria, Bucharest, Romania

[11] FILANTROPIA Clin Hosp Bucharest, Bucharest, Romania

[12] Provita Med Grp, Bucharest, Romania

[13] Bucharest Univ Emergency Hosp, Bucharest, Romania

[14] Clin Hosp Dr Ion Cantacuzino, Bucharest, Romania

[15] CMDTAMP Bucharest, Bucharest, Romania

[16] MedLife Breast Inst, Bucharest, Romania

[17] Euroclin Hosp Regina Maria, Bucharest, Romania

[18] MedLife Titan Hosp, Bucharest, Romania

[19] Genekor SA, Athens, Greece

[20] Fundeni Clin Inst Bucharest, Bucharest, Romania

[21] Clin Emergency Hosp Bucharest, Bucharest, Romania

[22] Neolife Clin Bucharest, Bucharest, Romania

[23] Agrippa Ionescu Hosp, Bucharest, Romania

来源：

BREAST | 2025年 / 80卷

关键词：

D O I：

10.1016/j.breast.2025.103934

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P051

引用

页数：2

共 50 条

[41] Utility of Oncotype DX score in clinical management for T1 estrogen receptor positive, HER2 negative, and lymph node negative breast cancer
Nguyen, Thi Truc Anh
Postlewait, Lauren M.
Zhang, Chao
Meisel, Jane L.
O'Regan, Ruth
Badve, Sunil
Kalinsky, Kevin
Li, Xiaoxian
BREAST CANCER RESEARCH AND TREATMENT, 2022, 192 (03) : 509 - 516
[42] ASO Visual Abstract: Sociodemographic and Clinical Predictors of Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast Cancer
Emilie D. Duchesneau
Selena J. An
Paula D. Strassle
Katherine Reeder-Hayes
Kristalyn K. Gallagher
David W. Ollila
Stephanie M. Downs-Canner
Philip M. Spanheimer
Annals of Surgical Oncology, 2022, 29 : 3062 - 3063
[43] \HER-2/neu Overexpression as Prognostic Factor in Small Size Breast Cancer (pT1, N0, M0)
Petroni, S.
Giotta, F.
Asselti, M.
Quero, C.
Marzano, A. L.
Giannone, G.
Rubini, V.
Simone, G.
EUROPEAN JOURNAL OF CANCER, 2012, 48 : S134 - S134
[44] ASO Visual Abstract: Sociodemographic and Clinical Predictors of Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast Cancer
Duchesneau, Emilie D.
An, Selena J.
Strassle, Paula D.
Reeder-Hayes, Katherine
Gallagher, Kristalyn K.
Ollila, David W.
Downs-Canner, Stephanie M.
Spanheimer, Philip M.
ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (05) : 3062 - 3063
[45] ASO Author Reflections: Oncotype DX RS Complementing the Prognostic Stage in the Updated AJCC 8th Edition for T1-2N1M0 ER-Positive HER2-Negative Breast Cancer
Wang, Maoli
Wu, Kejin
Chen, Hongliang
ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (05) : 1236 - 1237
[46] ASO Author Reflections: Oncotype DX RS Complementing the Prognostic Stage in the Updated AJCC 8th Edition for T1-2N1M0 ER-Positive HER2-Negative Breast Cancer
Maoli Wang
Kejin Wu
Hongliang Chen
Annals of Surgical Oncology, 2019, 26 : 1236 - 1237
[47] Patient Selection for Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast Cancer in the National Cancer Database
Duchesneau, Emilie D.
An, Selena J.
Strassle, Paula D.
Reeder-Hayes, Katherine
Gallagher, Kristalyn K.
Ollila, David W.
Downs-Canner, Stephanie M.
Spanheimer, Philip M.
ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 2) : S323 - S324
[48] Clinical algorithm to predict who may benefit from CDK4/6 inhibitors in patients (p) with estrogen receptor positive and HER-2 negative (ER+/Her2-) metastatic breast cancer (MBC).
Felip-Falgas, Eudald
Teruel, Iris
Garcia Mosquera, Juan Jose
Erasun, Carlos
Quiroga Garcia, Vanesa
Angelats, Laura
Espana, Sofia
Cucurull, Marc
Cirauqui, Beatriz
Margeli Vila, Mireia
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[49] Pathologic complete response and survival after neoadjuvant chemotherapy in cT1-T2/N0 HER2+ breast cancer
Selena J. An
Emilie D. Duchesneau
Paula D. Strassle
Katherine Reeder-Hayes
Kristalyn K. Gallagher
David W. Ollila
Stephanie M. Downs-Canner
Philip M. Spanheimer
npj Breast Cancer, 8
[50] Pathologic complete response and survival after neoadjuvant chemotherapy in cT1-T2/N0 HER2+ breast cancer
An, Selena J.
Duchesneau, Emilie D.
Strassle, Paula D.
Reeder-Hayes, Katherine
Gallagher, Kristalyn K.
Ollila, David W.
Downs-Canner, Stephanie M.
Spanheimer, Philip M.
NPJ BREAST CANCER, 2022, 8 (01)

← 1 2 3 4 5 →